1. Home
  2. BTM vs NKTX Comparison

BTM vs NKTX Comparison

Compare BTM & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bitcoin Depot Inc.

BTM

Bitcoin Depot Inc.

HOLD

Current Price

$1.33

Market Cap

112.0M

Sector

Finance

ML Signal

HOLD

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.84

Market Cap

133.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTM
NKTX
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.0M
133.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BTM
NKTX
Price
$1.33
$1.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$6.25
$13.25
AVG Volume (30 Days)
1.5M
650.8K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$635,643,000.00
N/A
Revenue This Year
$7.87
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.24
N/A
Revenue Growth
8.61
N/A
52 Week Low
$0.93
$1.31
52 Week High
$6.88
$2.74

Technical Indicators

Market Signals
Indicator
BTM
NKTX
Relative Strength Index (RSI) 30.82 45.33
Support Level $1.29 $1.81
Resistance Level $1.69 $1.90
Average True Range (ATR) 0.11 0.07
MACD 0.05 0.02
Stochastic Oscillator 8.75 52.50

Price Performance

Historical Comparison
BTM
NKTX

About BTM Bitcoin Depot Inc.

Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: